HEADER TRANSCRIPTION 06-JUL-00 1F93 TITLE CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE DIMERIZATION TITLE 2 DOMAIN OF HNF-1 ALPHA AND THE COACTIVATOR DCOH COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIMERIZATION COFACTOR OF HEPATOCYTE NUCLEAR COMPND 3 FACTOR 1-ALPHA; COMPND 4 CHAIN: A, B, C, D; COMPND 5 SYNONYM: PTERIN-4-ALPHA-CARBINOLAMINE DEHYDRATASE, PHS, COMPND 6 DCOH; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; COMPND 10 CHAIN: E, F, G, H; COMPND 11 FRAGMENT: DIMERIZATION DOMAIN (RESIDUES 1-32); COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 ORGAN: LIVER; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX GST FUSION PLASMID SOURCE 10 (PHARMACIA); SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: THIS PEPTIDE WAS CHEMICALLY SYNTHESIZED. SOURCE 14 THE SEQUENCE OF THIS PEPTIDE NATURALLY OCCURS IN MOUSE SOURCE 15 (MUS MUSCULUS) KEYWDS FOUR-HELIX BUNDLE, TRANSCRIPTIONAL ACTIVATOR/COACTIVATOR KEYWDS 2 COMPLEX, DIMERIZATION DOMAIN EXPDTA X-RAY DIFFRACTION AUTHOR R.B.ROSE,J.H.BAYLE,J.A.ENDRIZZI,J.D.CRONK,G.R.CRABTREE, AUTHOR 2 T.ALBER REVDAT 3 24-FEB-09 1F93 1 VERSN REVDAT 2 01-APR-03 1F93 1 JRNL REVDAT 1 20-SEP-00 1F93 0 JRNL AUTH R.B.ROSE,J.H.BAYLE,J.A.ENDRIZZI,J.D.CRONK, JRNL AUTH 2 G.R.CRABTREE,T.ALBER JRNL TITL STRUCTURAL BASIS OF DIMERIZATION, COACTIVATOR JRNL TITL 2 RECOGNITION AND MODY3 MUTATIONS IN HNF-1ALPHA. JRNL REF NAT.STRUCT.BIOL. V. 7 744 2000 JRNL REFN ISSN 1072-8368 JRNL PMID 10966642 JRNL DOI 10.1038/78966 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J. A.ENDRIZZI,J.D.CRONK,W.WEIDONG,G.R.CRABTREE, REMARK 1 AUTH 2 T.ALBER REMARK 1 TITL CRYSTAL STRUCTURE OF DCOH, A BIFUNCTIONAL, REMARK 1 TITL 2 PROTEIN-BINDING TRANSCRIPTIONAL COACTIVATOR REMARK 1 REF SCIENCE V. 268 556 1995 REMARK 1 REFN ISSN 0036-8075 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.D.CRONK,J.A.ENDRIZZI,T.ALBER REMARK 1 TITL HIGH-RESOLUTION STRUCTURES OF THE BIFUNCTIONAL REMARK 1 TITL 2 ENZYME AND TRANSCRIPTIONAL COACTIVATOR DCOH AND REMARK 1 TITL 3 ITS COMPLEX WITH A PRODUCT ANALOGUE REMARK 1 REF PROTEIN SCI. V. 5 1963 1996 REMARK 1 REFN ISSN 0961-8368 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.4 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH AND HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 912032.470 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 16569 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.257 REMARK 3 FREE R VALUE : 0.299 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1296 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.76 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2629 REMARK 3 BIN R VALUE (WORKING SET) : 0.3100 REMARK 3 BIN FREE R VALUE : 0.3710 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 8.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 230 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.024 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4044 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 62 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 43.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 58.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.32000 REMARK 3 B22 (A**2) : -2.19000 REMARK 3 B33 (A**2) : 6.51000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.73000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM SIGMAA (A) : 0.27 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.45 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.45 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.10 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.60 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.460 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 5.090 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 5.220 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 6.940 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 55.35 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: USED NON-CRYSTALLOGRAPHIC SYMMETRY REMARK 4 REMARK 4 1F93 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JUL-00. REMARK 100 THE RCSB ID CODE IS RCSB011394. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-98 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL1-5 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.06880 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16500 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.67 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.30000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: SHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.61 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, POTASSIUM SUCCINATE, PH REMARK 280 5.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 41.37500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A HETEROTETRAMER CONSISTING REMARK 300 OF A DCOH DIMER AND AN HNF-1 ALPHA DIMERIZATION DOMAIN REMARK 300 DIMER. THERE ARE TWO HETEROTETRAMERS IN THE REMARK 300 ASYMMETRIC UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4950 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -36.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4840 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12240 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -37.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A 1 REMARK 465 MSE B 1 REMARK 465 ALA B 2 REMARK 465 GLY B 3 REMARK 465 LYS B 4 REMARK 465 THR B 104 REMARK 465 MSE C 1 REMARK 465 ALA C 2 REMARK 465 GLY C 3 REMARK 465 LYS C 4 REMARK 465 ALA C 5 REMARK 465 MSE D 1 REMARK 465 ALA D 2 REMARK 465 GLY D 3 REMARK 465 LYS D 4 REMARK 465 GLU E 32 REMARK 465 MET F 1 REMARK 465 VAL F 2 REMARK 465 SER F 3 REMARK 465 LYS F 4 REMARK 465 GLU F 32 REMARK 465 MET G 1 REMARK 465 VAL G 2 REMARK 465 SER G 3 REMARK 465 GLY G 31 REMARK 465 GLU G 32 REMARK 465 MET H 1 REMARK 465 VAL H 2 REMARK 465 SER H 3 REMARK 465 LYS H 4 REMARK 465 GLY H 31 REMARK 465 GLU H 32 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 15 CG CD OE1 NE2 REMARK 470 LYS A 41 CG CD CE NZ REMARK 470 GLU B 11 CG CD OE1 OE2 REMARK 470 GLN B 15 CG CD OE1 NE2 REMARK 470 ARG B 88 CG CD NE CZ NH1 NH2 REMARK 470 GLN C 15 CG CD OE1 NE2 REMARK 470 LYS C 41 CG CD CE NZ REMARK 470 VAL C 101 CG1 CG2 REMARK 470 GLU D 11 CG CD OE1 OE2 REMARK 470 GLN D 15 CG CD OE1 NE2 REMARK 470 LYS D 36 CG CD CE NZ REMARK 470 LYS D 72 CG CD CE NZ REMARK 470 GLU D 87 CG CD OE1 OE2 REMARK 470 GLN D 98 CG CD OE1 NE2 REMARK 470 LYS G 4 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 70 -102.37 60.54 REMARK 500 SER A 78 149.19 -173.18 REMARK 500 LYS B 36 135.94 -170.53 REMARK 500 TYR B 70 -103.01 58.82 REMARK 500 LEU C 8 106.65 -56.90 REMARK 500 ALA C 10 -30.11 -39.98 REMARK 500 ARG C 31 122.48 178.97 REMARK 500 ASP C 32 89.90 -57.74 REMARK 500 TYR C 70 -102.71 60.18 REMARK 500 SER C 78 -175.30 -174.23 REMARK 500 HIS C 80 108.56 51.59 REMARK 500 GLU C 81 44.71 33.29 REMARK 500 CYS C 82 -64.40 -107.04 REMARK 500 ALA C 83 9.57 -167.13 REMARK 500 HIS D 6 -28.12 65.29 REMARK 500 ARG D 7 146.05 64.41 REMARK 500 LEU D 8 100.41 -49.86 REMARK 500 VAL D 23 -73.59 -51.20 REMARK 500 TYR D 70 -102.49 60.88 REMARK 500 SER D 78 -179.89 178.47 REMARK 500 HIS D 80 -72.54 -46.39 REMARK 500 GLU D 81 49.61 -52.39 REMARK 500 CYS D 82 -19.43 166.66 REMARK 500 GLU D 87 49.94 -71.83 REMARK 500 ARG D 88 -36.60 -158.69 REMARK 500 ALA D 100 -72.90 -48.39 REMARK 500 VAL E 2 -45.62 74.35 REMARK 500 SER E 3 -25.32 61.91 REMARK 500 LEU E 30 25.60 -76.00 REMARK 500 SER G 6 -165.46 -108.53 REMARK 500 REMARK 500 REMARK: NULL DBREF 1F93 A 1 104 UNP P61459 PHS_RAT 1 104 DBREF 1F93 B 1 104 UNP P61459 PHS_RAT 1 104 DBREF 1F93 C 1 104 UNP P61459 PHS_RAT 1 104 DBREF 1F93 D 1 104 UNP P61459 PHS_RAT 1 104 DBREF 1F93 E 1 32 UNP P22361 HNF1A_MOUSE 1 32 DBREF 1F93 F 1 32 UNP P22361 HNF1A_MOUSE 1 32 DBREF 1F93 G 1 32 UNP P22361 HNF1A_MOUSE 1 32 DBREF 1F93 H 1 32 UNP P22361 HNF1A_MOUSE 1 32 SEQADV 1F93 MSE A 1 UNP P61459 MET 1 MODIFIED RESIDUE SEQADV 1F93 MSE A 50 UNP P61459 MET 50 MODIFIED RESIDUE SEQADV 1F93 MSE A 103 UNP P61459 MET 103 MODIFIED RESIDUE SEQADV 1F93 MSE B 1 UNP P61459 MET 1 MODIFIED RESIDUE SEQADV 1F93 MSE B 50 UNP P61459 MET 50 MODIFIED RESIDUE SEQADV 1F93 MSE B 103 UNP P61459 MET 103 MODIFIED RESIDUE SEQADV 1F93 MSE C 1 UNP P61459 MET 1 MODIFIED RESIDUE SEQADV 1F93 MSE C 50 UNP P61459 MET 50 MODIFIED RESIDUE SEQADV 1F93 MSE C 103 UNP P61459 MET 103 MODIFIED RESIDUE SEQADV 1F93 MSE D 1 UNP P61459 MET 1 MODIFIED RESIDUE SEQADV 1F93 MSE D 50 UNP P61459 MET 50 MODIFIED RESIDUE SEQADV 1F93 MSE D 103 UNP P61459 MET 103 MODIFIED RESIDUE SEQRES 1 A 104 MSE ALA GLY LYS ALA HIS ARG LEU SER ALA GLU GLU ARG SEQRES 2 A 104 ASP GLN LEU LEU PRO ASN LEU ARG ALA VAL GLY TRP ASN SEQRES 3 A 104 GLU LEU GLU GLY ARG ASP ALA ILE PHE LYS GLN PHE HIS SEQRES 4 A 104 PHE LYS ASP PHE ASN ARG ALA PHE GLY PHE MSE THR ARG SEQRES 5 A 104 VAL ALA LEU GLN ALA GLU LYS LEU ASP HIS HIS PRO GLU SEQRES 6 A 104 TRP PHE ASN VAL TYR ASN LYS VAL HIS ILE THR LEU SER SEQRES 7 A 104 THR HIS GLU CYS ALA GLY LEU SER GLU ARG ASP ILE ASN SEQRES 8 A 104 LEU ALA SER PHE ILE GLU GLN VAL ALA VAL SER MSE THR SEQRES 1 B 104 MSE ALA GLY LYS ALA HIS ARG LEU SER ALA GLU GLU ARG SEQRES 2 B 104 ASP GLN LEU LEU PRO ASN LEU ARG ALA VAL GLY TRP ASN SEQRES 3 B 104 GLU LEU GLU GLY ARG ASP ALA ILE PHE LYS GLN PHE HIS SEQRES 4 B 104 PHE LYS ASP PHE ASN ARG ALA PHE GLY PHE MSE THR ARG SEQRES 5 B 104 VAL ALA LEU GLN ALA GLU LYS LEU ASP HIS HIS PRO GLU SEQRES 6 B 104 TRP PHE ASN VAL TYR ASN LYS VAL HIS ILE THR LEU SER SEQRES 7 B 104 THR HIS GLU CYS ALA GLY LEU SER GLU ARG ASP ILE ASN SEQRES 8 B 104 LEU ALA SER PHE ILE GLU GLN VAL ALA VAL SER MSE THR SEQRES 1 C 104 MSE ALA GLY LYS ALA HIS ARG LEU SER ALA GLU GLU ARG SEQRES 2 C 104 ASP GLN LEU LEU PRO ASN LEU ARG ALA VAL GLY TRP ASN SEQRES 3 C 104 GLU LEU GLU GLY ARG ASP ALA ILE PHE LYS GLN PHE HIS SEQRES 4 C 104 PHE LYS ASP PHE ASN ARG ALA PHE GLY PHE MSE THR ARG SEQRES 5 C 104 VAL ALA LEU GLN ALA GLU LYS LEU ASP HIS HIS PRO GLU SEQRES 6 C 104 TRP PHE ASN VAL TYR ASN LYS VAL HIS ILE THR LEU SER SEQRES 7 C 104 THR HIS GLU CYS ALA GLY LEU SER GLU ARG ASP ILE ASN SEQRES 8 C 104 LEU ALA SER PHE ILE GLU GLN VAL ALA VAL SER MSE THR SEQRES 1 D 104 MSE ALA GLY LYS ALA HIS ARG LEU SER ALA GLU GLU ARG SEQRES 2 D 104 ASP GLN LEU LEU PRO ASN LEU ARG ALA VAL GLY TRP ASN SEQRES 3 D 104 GLU LEU GLU GLY ARG ASP ALA ILE PHE LYS GLN PHE HIS SEQRES 4 D 104 PHE LYS ASP PHE ASN ARG ALA PHE GLY PHE MSE THR ARG SEQRES 5 D 104 VAL ALA LEU GLN ALA GLU LYS LEU ASP HIS HIS PRO GLU SEQRES 6 D 104 TRP PHE ASN VAL TYR ASN LYS VAL HIS ILE THR LEU SER SEQRES 7 D 104 THR HIS GLU CYS ALA GLY LEU SER GLU ARG ASP ILE ASN SEQRES 8 D 104 LEU ALA SER PHE ILE GLU GLN VAL ALA VAL SER MSE THR SEQRES 1 E 32 MET VAL SER LYS LEU SER GLN LEU GLN THR GLU LEU LEU SEQRES 2 E 32 ALA ALA LEU LEU GLU SER GLY LEU SER LYS GLU ALA LEU SEQRES 3 E 32 ILE GLN ALA LEU GLY GLU SEQRES 1 F 32 MET VAL SER LYS LEU SER GLN LEU GLN THR GLU LEU LEU SEQRES 2 F 32 ALA ALA LEU LEU GLU SER GLY LEU SER LYS GLU ALA LEU SEQRES 3 F 32 ILE GLN ALA LEU GLY GLU SEQRES 1 G 32 MET VAL SER LYS LEU SER GLN LEU GLN THR GLU LEU LEU SEQRES 2 G 32 ALA ALA LEU LEU GLU SER GLY LEU SER LYS GLU ALA LEU SEQRES 3 G 32 ILE GLN ALA LEU GLY GLU SEQRES 1 H 32 MET VAL SER LYS LEU SER GLN LEU GLN THR GLU LEU LEU SEQRES 2 H 32 ALA ALA LEU LEU GLU SER GLY LEU SER LYS GLU ALA LEU SEQRES 3 H 32 ILE GLN ALA LEU GLY GLU MODRES 1F93 MSE A 50 MET SELENOMETHIONINE MODRES 1F93 MSE A 103 MET SELENOMETHIONINE MODRES 1F93 MSE B 50 MET SELENOMETHIONINE MODRES 1F93 MSE B 103 MET SELENOMETHIONINE MODRES 1F93 MSE C 50 MET SELENOMETHIONINE MODRES 1F93 MSE C 103 MET SELENOMETHIONINE MODRES 1F93 MSE D 50 MET SELENOMETHIONINE MODRES 1F93 MSE D 103 MET SELENOMETHIONINE HET MSE A 50 8 HET MSE A 103 8 HET MSE B 50 8 HET MSE B 103 8 HET MSE C 50 8 HET MSE C 103 8 HET MSE D 50 8 HET MSE D 103 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 8(C5 H11 N O2 SE) FORMUL 9 HOH *62(H2 O) HELIX 1 1 SER A 9 VAL A 23 1 15 HELIX 2 2 ASP A 42 ASP A 61 1 20 HELIX 3 3 SER A 86 SER A 102 1 17 HELIX 4 4 SER B 9 VAL B 23 1 15 HELIX 5 5 ASP B 42 ASP B 61 1 20 HELIX 6 6 HIS B 80 ALA B 83 5 4 HELIX 7 7 SER B 86 MSE B 103 1 18 HELIX 8 8 SER C 9 ALA C 22 1 14 HELIX 9 9 ASP C 42 ASP C 61 1 20 HELIX 10 10 SER C 86 SER C 102 1 17 HELIX 11 11 SER D 9 GLY D 24 1 16 HELIX 12 12 ASP D 42 ASP D 61 1 20 HELIX 13 13 ARG D 88 SER D 102 1 15 HELIX 14 14 SER E 6 SER E 19 1 14 HELIX 15 15 SER E 22 LEU E 30 1 9 HELIX 16 16 SER F 6 SER F 19 1 14 HELIX 17 17 SER F 22 LEU F 30 1 9 HELIX 18 18 SER G 6 SER G 19 1 14 HELIX 19 19 SER G 22 LEU G 30 1 9 HELIX 20 20 SER H 6 SER H 19 1 14 HELIX 21 21 SER H 22 LEU H 30 1 9 SHEET 1 A 8 ASN A 26 GLU A 27 0 SHEET 2 A 8 ILE A 34 HIS A 39 -1 N PHE A 35 O ASN A 26 SHEET 3 A 8 LYS A 72 LEU A 77 -1 N VAL A 73 O PHE A 38 SHEET 4 A 8 GLU A 65 VAL A 69 -1 N GLU A 65 O THR A 76 SHEET 5 A 8 GLU B 65 VAL B 69 -1 O TRP B 66 N ASN A 68 SHEET 6 A 8 LYS B 72 LEU B 77 -1 N LYS B 72 O VAL B 69 SHEET 7 A 8 ILE B 34 HIS B 39 -1 O ILE B 34 N LEU B 77 SHEET 8 A 8 ASN B 26 GLU B 27 -1 O ASN B 26 N PHE B 35 SHEET 1 B 8 ASN C 26 GLU C 27 0 SHEET 2 B 8 ILE C 34 HIS C 39 -1 N PHE C 35 O ASN C 26 SHEET 3 B 8 LYS C 72 LEU C 77 -1 N VAL C 73 O PHE C 38 SHEET 4 B 8 GLU C 65 VAL C 69 -1 N GLU C 65 O THR C 76 SHEET 5 B 8 GLU D 65 VAL D 69 -1 O TRP D 66 N ASN C 68 SHEET 6 B 8 ILE D 34 HIS D 39 -1 O ILE D 34 N LEU D 77 SHEET 7 B 8 ASN D 26 GLU D 27 -1 O ASN D 26 N PHE D 35 LINK C PHE A 49 N MSE A 50 1555 1555 1.33 LINK C MSE A 50 N THR A 51 1555 1555 1.33 LINK C SER A 102 N MSE A 103 1555 1555 1.33 LINK C MSE A 103 N THR A 104 1555 1555 1.33 LINK C PHE B 49 N MSE B 50 1555 1555 1.33 LINK C MSE B 50 N THR B 51 1555 1555 1.33 LINK C SER B 102 N MSE B 103 1555 1555 1.33 LINK C PHE C 49 N MSE C 50 1555 1555 1.33 LINK C MSE C 50 N THR C 51 1555 1555 1.33 LINK C SER C 102 N MSE C 103 1555 1555 1.33 LINK C MSE C 103 N THR C 104 1555 1555 1.33 LINK C PHE D 49 N MSE D 50 1555 1555 1.33 LINK C MSE D 50 N THR D 51 1555 1555 1.33 LINK C SER D 102 N MSE D 103 1555 1555 1.33 LINK C MSE D 103 N THR D 104 1555 1555 1.33 CRYST1 49.480 82.750 70.640 90.00 97.83 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020210 0.000000 0.002779 0.00000 SCALE2 0.000000 0.012085 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014290 0.00000 MASTER 347 0 8 21 15 0 0 6 0 0 0 44 END